Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Statistics & Valuation Metrics

Shuttle Pharmaceuticals Holdings, Inc. has a market cap or net worth of $2.87M. The enterprise value is ―.

Shuttle Pharmaceuticals Holdings, Inc. has 1,603,285 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shuttle Pharmaceuticals Holdings, Inc.’s return on equity (ROE) is -12.90K and return on invested capital (ROIC) is -403383.29%.

The current PE Ratio of Shuttle Pharmaceuticals Holdings, Inc. is ―. Shuttle Pharmaceuticals Holdings, Inc.’s PEG ratio is >-0.00001.

In the last 12 months, Shuttle Pharmaceuticals Holdings, Inc. had revenue of 0.00 and earned -9.14M in profits. Earnings per share was -885.73.

In the last 12 months, operating cash flow was -11.20M and capital expenditures 6.00, giving a free cash flow of -11.20M billion.

Shuttle Pharmaceuticals Holdings, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Shuttle Pharmaceuticals Holdings, Inc. upcoming earnings date is ―, ―.

Shuttle Pharmaceuticals Holdings, Inc. as a current ratio of 1.44, with Debt / Equity ratio of 47.87%

In the past 12 months, Shuttle Pharmaceuticals Holdings, Inc. has paid 0.00 in taxes.

Shuttle Pharmaceuticals Holdings, Inc. EV to EBITDA ratio is -28.41, with an EV/FCF ratio of -30.16.

Shuttle Pharmaceuticals Holdings, Inc. has $2.09M in cash and marketable securities with $667.33K in debt, giving a net cash position of $1.43M billion.

Gross margin is -48.78%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Shuttle Pharmaceuticals Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―